Skip to main content
Fig. 2 | BMC Cardiovascular Disorders

Fig. 2

From: Cardiovascular risk associated with the use of glitazones, metformin and sufonylureas: meta-analysis of published observational studies

Fig. 2

Relative risk of acute myocardial infarction and stroke in rosiglitazone users compared with pioglitazone users. AMI, acute myocardial infarction; IV, inverse variance. Red bars, percentage of items in the RTI item bank indicating high risk of bias; yellow bars, percentage of items at unclear risk of bias. Items with low risk of bias not shown. Denominators indicate the number of items evaluated for each study.

Back to article page